Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. April 2026 16:35 ET | Quelle: Legence Corp

Legence Announces Closing of Upsized Secondary Underwritten Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that it has closed its upsized secondary underwritten public offering...
07. April 2026 21:24 ET | Quelle: Legence Corp

Legence Announces Pricing of Upsized Secondary Underwritten Public Offering of Class A Common Stock

SAN JOSE, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced the pricing of an upsized secondary underwritten public offering (the...
06. April 2026 07:24 ET | Quelle: Legence Corp

Legence Announces Secondary Underwritten Public Offering of Class A Common Stock

SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that selling stockholders affiliated with Blackstone Inc. (the “Selling...
03. April 2026 09:00 ET | Quelle: Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Announces Changes to Board of Directors

-- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage...